Histopathological grading of laryngectomy specimens

APMIS

Volumn 113, Issue 7-8, 2005, Pages 473-488

  Vermund, Halvor ^a   Krajci, Peter ^b   Eide, Tor J ^a   Winther, Finn ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Cancer; Histological grading; Larynx

Indexed keywords

ARTICLE; CANCER GRADING; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY DIAGNOSIS; LARYNGECTOMY; LYMPH NODE METASTASIS; MULTIPLE REGRESSION; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TECHNIQUE;

CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; HUMANS; KERATINS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; LYMPHATIC METASTASIS; PROGNOSIS; RECURRENCE;

EID: 23144467118     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2005.apm_24.x     Document Type: Article

References (56)

1. Broders AC. Carcinoma of the mouth: types and degrees of malignancy. Am J Roentgen Radium Ther 1927;17:90-103.
2. Dixon WJ. BMDP Statistical Software Manual. University of California Press 1992;1:390-5 II: 386-93.
3. McGavran MH, Bauer WC, Ogura JH. The incidence of cervical lymph node metastases from epidermoid carcinoma of the larynx and their relationship to certain characteristics of the primary tumor. Cancer 1961;14:55-66.
4. McDonald TJ, DeSanto LW, Weiland LH. Supraglottic larynx and its pathology as studied by whole laryngeal sections. Laryngoscope 1976;86: 635-48.
5. Sessions DG. Surgical pathology of cancer of the larynx and hypopharynx. Laryngoscope 1976;86: 814-39.
6. Mills EED. Early glottic carcinoma: factors affecting radiation failure, results of treatment and sequelae. Int J Radiat Oncol Biol Phys 1979;5: 811-7.
7. Chung CK, Stryker JA, Abt AB, et al Histologic grading in the clinical evaluation of laryngeal carcinoma. Arch Otolaryngol 1980;106:623-4.
8. Foote RL, Olsen KD, Buskirk SJ, et al Laryngectomy alone for T3 glottic cancer. Head Neck 1994;16:406-12.
9. Resnick JM, Uhlman D, Niehans GA, et al Cervical lymph node status and survival in laryngeal carcinoma: prognostic factors. Ann Otol Rhinol Laryngol 1995;104:685-94.
10. Geelen CP, Hordijk GJ, Ravasz LA, et al Degree of tumour differentiation as a prognostic factor in advanced laryngeal cancer. Acta Oto-Rhino-Laryngol Belgica 1995;49:1-4.
11. Small W, Mittal BB, Brand WN, et al. Results of radiation therapy in early glottic carcinoma: multivariate analysis of prognostic and radiation therapy variables. Radiology 1992;183:789-94.
12. Pera E, Moreno A, Galindo L. Prognostic factors in laryngeal carcinoma. A multifactorial study of 416 cases. Cancer 1986;58:928-34.
13. Underskog I, Sorbe B, Persson JE. Radiation treatment of laryngeal carcinoma with special reference to CRE values. Acta Radiol Oncol 1985;24:227-32.
14. Olszewski SJ, Vaeth JM, Green JP, et al The influence of field size, treatment modality, commissure involvement and histology in the treatment of early vocal cord cancer with irradiation. Int J Radiat Oncol Biol Phys 1985;11:1333-7.
15. Vendelbo Johansen L, Overgaard J, Hjelm-Hansen M, et al. Primary radiotherapy of T1 squamous cell carcinoma of the larynx: analysis of 478 patients treated from 1963 to 1985. Int J Radiat Oncol Phys Biol 1990;18:1307-13.
16. Pisani P, Krengli M. Results of functional laterocervical dissection associated with postoperative radiotherapy in 102 cases of carcinoma of the larynx with lymph node metastases. G Ital Oncol 1989;9:87-91.
17. Rube C, Micke O, Grevers G, et al Primare Strahlentherapie des Larynxcarcinoms. Strahlenther Onkol 1997;173:83-90.
18. Overgaard J, Sand Hansen H, Jorgensen K, et al Primary radiotherapy of larynx and pharynx: an analysis of some factors influencing local control and survival. Int J Radiat Oncol Biol Phys 1986; 12:515-21.
19. Manni JJ, Terhaard CHJ, de Boer MF, et al. Prognostic factors for survival in patients with T3 laryngeal carcinoma. Am J Surg 1992;164: 682-7.
20. Viani L, Stell PM, Dalby JE. Recurrence after radiotherapy for glottic carcinoma. Cancer 1991;67:577-84.
21. Suarez Nieto C, Herrera Monge F, Diaz Fernandez C, et al. Clinicopathologic prognostic factors in laryngeal pharyngolaryngeal tumors. II. Glottic carcinomas. Acta Otorrinolaringol Esp 1993; 44:77-83.
22. van Acht MJ, Hermans J, Dolsma WV, et al Glottic and supraglottic carcinoma: a retrospective comparison of radiotherapy alone with sandwich therapy in 366 patients. Radiother Oncol 1989;14:103-12.
23. Eiband JD, Elias EG, Suter CM. Prognostic factors in squamous cell carcinoma of the larynx. Am J Surg 1989;158:314-7.
24. Helweg-Larsen K, Graem N, Meistrup-Larsen KI. Clinical relevance of histological grading of cancer of the larynx. Acta path microbiol scand 1978;86A:499-504.
25. Pradier R, Gonzales A, Matos E, et al Prognostic factors in laryngeal carcinoma. Experience in 296 male patients. Cancer 1993;71:2472-6.
26. Terhaard CHJ, Snippe K, Ravasz LA, et al. Radiotherapy in T1 laryngeal cancer: prognostic factors for locoregional control and survival, uni- and multivariate analysis. Int J Radiat Oncol 1991;21:1179-86.
27. McLean M. Primary management of limited laryngeal cancer by radiotherapy and surgical salvage: results of 164 cases treated in a district hospital. Clin Oncol (R Coll Radiol) 1989;1:97-100.
28. Stein M, Rosenblatt E, Kuten A, et al Results of radiation therapy in early glottic carcinoma (T1,T2N0). J Surg Oncol 1989;40:173-6.
29. Soo KC, Shah JP, Gopinath KS, et al. Analysis of prognostic variables and results after supraglottic partial laryngectomy. Am J Surg 1988;156: 301-5.
30. Lee SS, Ro JY, Luna MA, et al. Squamous cell carcinoma of the larynx in young adults. Semin Diagn Pathol 1987;4:150-2.
31. Nielsen J. Functional results and permanence of cure following roentgentherapy of intralaryngeal carcinomas. J Fac Radiol 1951;3:29-34.
32. Blumlein H. Zur Frage der Beziehungen zwischen histological Aufbau und klinische Verlauf des Kehlkopfcarcinoms. Arch Ohren-Heilk 1967;170: 317-23.
33. Michaels L. Differentiation of squamous carcinoma of the larynx as a determinant of prognosis. Canad J Otolaryngol 1975;4:873-80.
34. Jakobsson PA. Histologic classification and grading of malignancy in carcinoma of the larynx. Acta Radiol Ther Phys Biol 1973;12:1-8.
35. Jakobsson PA. Histologic grading of malignancy and prognosis of glottic carcinoma of the larynx. Canad J Otolaryngol 1975;4:885-92.
36. Lund C, Sogaard H, Jorgensen K, et al Epidermoid carcinoma of the larynx. VI. Histologic grading in the clinical evaluation. Acta Radiol Ther Phys Biol 1976;15:292-304.
37. Lund C, Jorgensen K, Hjelm-Hansen M, et al. Laryngeal carcinoma. III. Treatment results in relation to microscopic score. Acta Radiol Oncol Radiat Phys Biol 1979;18:497-506.
38. Solano J, Esteban F, Delgado M, et al. Histopathological malignancy and prognosis of laryngeal cancer. Acta Otorrinolaringol Esp 1997;48: 375-82.
39. Glanz HK. Carcinoma of the larynx. Growth, p-classification and grading of squamous cell carcinoma of the vocal cords. Adv Otorhinolaryngol 1984;32:1-123.
40. Glanz H, Eichhorn T. Die prognostische Bedeutung des histologischen "Gradings" von Stimmlippenkarzinomen. HNO 1985;33:103-11.
41. Lobe LP, Quade R. Histopathologic grading of ENT carcinomas. Laryngol Rhinol Otol 1982;61: 171-82.
42. Boheim K, Spoendlin H. The effect of chemotherapy in relation to pathohistological tumour grading in head and neck cancer. Arch Otorhinolaryngol 1983;238:197-204.
43. Franzen G, Olofsson J, Klintenberg C, et al. Prognostic value of malignancy grading and DNA measurements in small glottic carcinomas. ORL J Otorhinolaryngol Relat Spec 1987;49:73-8.
44. Graem N, Helweg-Larsen K, Keiding N. Precision of histological grading of malignancy. Acta path microbiol scand 1980;88:307-17.
45. Helweg-Larsen K, Graem N, Meistrup-Larsen KI. Clinical relevance of histological grading of cancer of the larynx. Acta path microbiol scand 1978;86A:499-504.
46. Bryne M, Jenssen N, Boysen M. Histologic grading in the deep invasive front of T1 and T2 glottic squamous cell carcinomas has high prognostic value. Virchows Arch 1995;427:277-81.
47. Krecicki T, Jelen M, Zalesska-Krecicka M, et al Prognostic value of nucleolar organizer regions (AgNORs) in laryngeal cancer. Acta Otorhinolaryngol Belg 1998;52:215-21.
48. Yamamoto Y, Itch T, Saka T, et al. Prognostic value of nucleolar organizer regions in supraglottic carcinoma. Auris Nasus Larynx 1997;24: 85-90.
49. Perez Carro Rios A, Garcia Caballero T, Lozano Ramirez A, et al. The relationship between survival and cell proliferation index in squamous cell carcinoma of larynx. Rev Laryngol Otol Rhinol (Bord) 2000;121:121-5.
50. Pulkkinen JO, Klemi P, Martikainen P, et al. Apoptosis in situ, p53, bcl-2 and AgNOR counts as prognostic factors in laryngeal carcinoma. Anticancer Res 1999;19:703-8.
51. Truelson JM, Fisher SG, Beals TE, et al. DNA content and histological growth pattern correlate with prognosis in patients with advanced squamous cell carcinoma of the larynx. Cancer 1992;70: 56-62.
52. Foote RL, Buskirk SJ, Stanley RJ, et al. Patterns of failure after total laryngectomy for glottic carcinoma. Cancer 1989;64:143-9.
53. Sand Hansen H. Neoplasma malignum larynges. Copenhagen: Polyteknisk Forlag, 1975:29;113, 164, 179, 220.
54. Bennett SH, Futrell JW, Roth JA, et al. Prognostic significance of histologic host response in cancer of the larynx or hypopharynx. Cancer 1971;28:1255-65.
55. Zechner G, Lauerma S. Larynxkarzinom und Fernmetastasen. Monatsschr Ohrenheilkd Laryngorhinol 1967;101:431-40.
56. Horiot JC, Fletcher GH, Ballantyne AJ, et al. Analysis of failures in early vocal cord cancer. Radiology 1972;103:663-5.